These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36215918)

  • 21. Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study.
    Gronich N; Lavi I; Lejbkowicz F; Pinchev M; Zoabi Y; Auriel E; Saliba W; Rennert G
    Pharmacogenomics J; 2021 Jun; 21(3):402-408. PubMed ID: 33649514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis.
    Jafrin S; Naznin NE; Reza MS; Aziz MA; Islam MS
    Eur J Intern Med; 2021 Aug; 90():49-65. PubMed ID: 34092486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
    Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X
    Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials.
    Sheng XY; An HJ; He YY; Ye YF; Zhao JL; Li S
    J Clin Pharm Ther; 2022 Aug; 47(8):1112-1121. PubMed ID: 35396752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease.
    Patel PD; Vimalathas P; Niu X; Shannon CN; Denny JC; Peterson JF; Chitale RV; Fusco MR
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105464. PubMed ID: 33246208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.
    Doll JA; Neely ML; Roe MT; Armstrong PW; White HD; Prabhakaran D; Winters KJ; Duvvuru S; Sundseth SS; Jakubowski JA; Gurbel PA; Bhatt DL; Ohman EM; Fox KAA;
    J Am Coll Cardiol; 2016 Mar; 67(8):936-947. PubMed ID: 26916483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke.
    Zhang S; Lai X; Li W; Xiong Z; Xu A; Xu A; Huang L
    Thromb Res; 2014 Dec; 134(6):1272-7. PubMed ID: 25457586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study.
    Fu H; Hu P; Ma C; Peng F; He Z
    Medicine (Baltimore); 2020 Apr; 99(15):e19472. PubMed ID: 32282698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study.
    Lin J; Mo Y; Cai D; Mao D; Fu H; Wei D
    Ann Palliat Med; 2021 Dec; 10(12):12171-12180. PubMed ID: 35016407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
    Subraja K; Dkhar SA; Priyadharsini R; Ravindra BK; Shewade DG; Satheesh S; Sridhar MG; Narayan SK; Adithan C
    Eur J Clin Pharmacol; 2013 Mar; 69(3):415-22. PubMed ID: 22955794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.
    Jeong TD; Kim SM; Kim HJ; Lee W; Kwon SU; Min WK; Kang DW; Chun S
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):440-6. PubMed ID: 25529343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Yi X; Zhou Q; Wang C; Lin J; Chai Z
    J Neurol; 2018 Oct; 265(10):2396-2403. PubMed ID: 30128710
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Pan Y; Wangqin R; Li H; Wang Y; Meng X; Johnston SC; Simon T; Lin J; Zhao X; Liu L; Wang D; Wang Y
    Neurology; 2021 Jan; 96(1):e1-e9. PubMed ID: 33093222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.
    Rath CL; Jørgensen NR; Wienecke T
    PLoS One; 2020; 15(12):e0236260. PubMed ID: 33370281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis.
    Hou X; Shi J; Sun H
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1041-7. PubMed ID: 24996381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of CYP2C19 and F2R genetic polymorphisms with platelet reactivity in Chinese ischemic stroke patients receiving clopidogrel therapy.
    Zhang S; Zhu J; Li H; Li F; Zhu B; Li T; Fang S; Qin S
    Pharmacogenet Genomics; 2022 Jun; 32(4):138-143. PubMed ID: 34954768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2C19 Loss-of-Function Associated with First-Time Ischemic Stroke in Non-surgical Asymptomatic Carotid Artery Stenosis During Clopidogrel Therapy.
    Patel PD; Niu X; Shannon CN; Denny JC; Peterson JF; Fusco MR; Chitale RV
    Transl Stroke Res; 2022 Feb; 13(1):46-55. PubMed ID: 33611730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis.
    Alakbarzade V; Huang X; Ster IC; McEntagart M; Pereira AC
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104877. PubMed ID: 32414579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack.
    Wang T; Pan Y; Lin J; Anand R; Wang D; Johnston SC; Meng X; Li H; Zhao X; Liu L; Wang Y; Wang Y;
    Eur J Neurol; 2019 Sep; 26(9):1175-1182. PubMed ID: 30974489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.
    Pan Y; Chen W; Xu Y; Yi X; Han Y; Yang Q; Li X; Huang L; Johnston SC; Zhao X; Liu L; Zhang Q; Wang G; Wang Y; Wang Y
    Circulation; 2017 Jan; 135(1):21-33. PubMed ID: 27806998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.